US Patent 11406644 Tropomyosin-related kinase (TRK) inhibitors
Patent 11406644 was granted and assigned to Genzyme on August, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 25, 2020
Date of Patent
August 9, 2022
Patent Applicant
Patent Application Number
17032692
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11406644 Tropomyosin-related kinase (TRK) inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.